SEC Form 4 · accession 0001511164-17-000753
INVO Bioscience, Inc. · IVOB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Claude Ranoux
10% Owner
Period of report
Dec 14, 2017
Accepted (ET)
Dec 18, 2017 · 10:36 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001417926
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| INVO Bioscience Common Stock | Dec 14, 2017 | S | 10,000 | $0.172 | D | 26,223,122 | D | |
| INVO Bioscience Common Stock | Dec 18, 2017 | S | 20,000 | $0.17 | D | 26,203,122 | D |
Table II — derivative securities
No Table II lines on this filing.